Cargando…
Exploring beyond the limit: How comparative stochastic performance affects retesting outcomes in six commercial SARS CoV-2 nucleic acid amplification tests
OBJECTIVES: To examine the comparative stochasticity profile of six commercial SARS-CoV-2 nucleic acid amplification tests (NAATs) and how this may affect retesting paradigms. METHODS: Commercial quality control (QC) material was serially diluted in viral transport media to create a panel covering 1...
Autores principales: | Chan, Hiu Tat, Keung, Marco H.T., Nguyen, Ivy, Ip, Ellen L.O., Chew, Su M., Siler, Danielle, Saville, Marion, Hawkes, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055756/ https://www.ncbi.nlm.nih.gov/pubmed/35528049 http://dx.doi.org/10.1016/j.jcvp.2022.100079 |
Ejemplares similares
-
Clinical evaluation of commercial nucleic acid amplification tests in patients with suspected sepsis
por: Ljungström, Lars, et al.
Publicado: (2015) -
Comparative evaluation of six nucleic acid amplification kits for SARS-CoV-2 RNA detection
por: Wu, Shuang, et al.
Publicado: (2021) -
Commercial Nucleic-Acid Amplification Tests for Diagnosis of Pulmonary Tuberculosis in Respiratory Specimens: Meta-Analysis and Meta-Regression
por: Ling, Daphne I., et al.
Publicado: (2008) -
Design considerations for point-of-need devices based on nucleic acid amplification for COVID-19 diagnostics and beyond
por: Zhang, Haoqing, et al.
Publicado: (2021) -
Isothermal Amplification of Nucleic Acids Coupled with Nanotechnology and Microfluidic Platforms for Detecting Antimicrobial Drug Resistance and Beyond
por: Alamolhoda, Seyedeh Zahra, et al.
Publicado: (2022)